atranorin has been researched along with lecanoric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii-Kuriyama, Y; Hayashi, H; Inoue, M; Nakashima, K; Tanabe, H | 1 |
| Antreich, SJ; Bačkor, M; Goga, M; Lang, I; Weckwerth, W | 1 |
| Erkoc, P; Fürst, R; Geisslinger, G; Henke, M; Ingelfinger, R; Laux, V; Roser, LA; Schiffmann, S; Schmitt, I; Schneider, AK; Ulshöfer, T | 1 |
3 other study(ies) available for atranorin and lecanoric acid
| Article | Year |
|---|---|
Atranorin and lecanoric acid antagonize TCDD-induced xenobiotic response element-driven activity, but not xenobiotic response element-independent activity.
Topics: Animals; Hep G2 Cells; Humans; Hydroxybenzoates; Lichens; Receptors, Aryl Hydrocarbon; Salicylates; Transfection | 2016 |
Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
Topics: Allelopathy; Benzofurans; Bryopsida; Cell Division; Cell Size; Germ Cells, Plant; Heterocyclic Compounds, 3-Ring; Hydroxybenzoates; Lichens; Plant Extracts; Salicylates; Secondary Metabolism | 2017 |
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin B1; Endothelial Cells; HEK293 Cells; Histones; Humans; Hydroxybenzoates; Lichens; Mice; Mitosis; NIH 3T3 Cells; Salicylates | 2022 |